MDCO almost has to make a deal for a marketed or late-stage compound to divert investor attention from the Angiomax fiasco and to keep the salesforce busy come 2010.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.